| References |
Top |
| REF 1 |
Important role of SUMOylation of Spliceosome factors in prostate cancer cells. J Proteome Res. 2014 Aug 1;13(8):3571-82.
|
| REF 2 |
The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J. 2006 Jul 15;397(2):279-88.
|
| REF 3 |
Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation. Oncotarget. 2016 Sep 13;7(37):58995-59005.
|
| REF 4 |
SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat Struct Mol Biol. 2006 Dec;13(12):1069-77.
|
| REF 5 |
SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J Cell Biol. 2006 Sep 25;174(7):939-49.
|
| REF 6 |
Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem. 2006 Jun 9;281(23):15869-77.
|
| REF 7 |
Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 2012 Oct;13(10):930-8.
|
| REF 8 |
The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression. J Biol Chem. 2018 Oct 5;293(40):15439-15454.
|
